Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
|
CN |
|
Samuel Heath and Sons PLC
LSE:HSM
|
UK |
Income Statement
Earnings Waterfall
Beijing Luzhu Biotechnology Co Ltd
Income Statement
Beijing Luzhu Biotechnology Co Ltd
| Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
1
|
1
|
1
|
3
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||
| Operating Expenses |
(246)
|
(292)
|
(182)
|
(137)
|
|
| Selling, General & Administrative |
(87)
|
(91)
|
(65)
|
(46)
|
|
| Research & Development |
(173)
|
(220)
|
(135)
|
(105)
|
|
| Other Operating Expenses |
14
|
18
|
18
|
14
|
|
| Operating Income |
(246)
N/A
|
(292)
-19%
|
(182)
+38%
|
(137)
+25%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
23
|
13
|
14
|
7
|
|
| Non-Reccuring Items |
(26)
|
0
|
(0)
|
(6)
|
|
| Total Other Income |
(1)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(249)
N/A
|
(280)
-12%
|
(168)
+40%
|
(136)
+19%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(249)
|
(280)
|
(168)
|
(136)
|
|
| Net Income (Common) |
(249)
N/A
|
(280)
-12%
|
(168)
+40%
|
(136)
+19%
|
|
| EPS (Diluted) |
-1.25
N/A
|
-1.38
-10%
|
-0.83
+40%
|
-0.68
+18%
|
|